| Company name | National Research Corporation |
| Stock ticker | NRCI |
| Live stock price | [stckqut]NRCI[/stckqut] |
| P/E compared to competitors | Good |
MANAGEMENT EXECUTION
| Employee productivity | Poor |
| Sales growth | Good |
| EPS growth | Good |
| P/E growth | Poor |
| EBIT growth | Good |
ANALYSIS
| Confident Investor Rating | Fair |
| Target stock price (TWCA growth scenario) | $63.23 |
| Target stock price (averages with growth) | $71.96 |
| Target stock price (averages with no growth) | $51.31 |
| Target stock price (manual assumptions) | $57.73 |
The following company description is from Google Finance: http://www.google.com/finance?q=nrci
National Research Corporation (NRC) is a provider of performance measurement and improvement services, healthcare analytics and governance education to the healthcare industry in the United States and Canada. The Company’s portfolio of services addresses the needs of healthcare organizations to measure and improve satisfaction, outcomes relative to the services that they provide. The Company’s services include data collection, healthcare analytics, practice identification and delivery of value-added business intelligence that enables its clients to improve performance across key business metrics. NRC also provides healthcare information services to organizations across a range of service delivery segments. The Company has seven operating segments aggregated into one. These include NRC Picker U.S., NRC Picker Canada, Ticker, Payer Solutions, the Governance Institute (TGI), My InnerView (MIV) and Illuminate.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.